LULU MOHAMED ALBAKRI: Open Payments
NPI 1447030192 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 60 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $362 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $282 |
| ABBVIE INC. | 13 | $234 |
| PFIZER INC. | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Kowa Pharmaceuticals America, Inc. | 4 | $64 |
| Amgen Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $32 |
Products named: Wegovy, UBRELVY, QULIPTA, LEQVIO, BREZTRI, ZORYVE, Rybelsus, MOUNJARO.
Industry payments across OH — which companies pay providers there.
